United States v. Ratti

365 F. Supp. 2d 649, 2005 U.S. Dist. LEXIS 6268, 2005 WL 878093
CourtDistrict Court, D. Maryland
DecidedFebruary 1, 2005
DocketCrim. PJM 03-0330
StatusPublished
Cited by2 cases

This text of 365 F. Supp. 2d 649 (United States v. Ratti) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Ratti, 365 F. Supp. 2d 649, 2005 U.S. Dist. LEXIS 6268, 2005 WL 878093 (D. Md. 2005).

Opinion

AMENDED OPINION

MESSITTE, District Judge.

I. Introduction

Luigi Ratti has been charged in a Superseding Indictment with six counts of wire fraud in violation of 18 U.S.C. § 1343; one count of conspiracy in violation of 18 U.S.C. § 371; three counts of false statement within the jurisdiction of a federal agency in violation of 18 U.S.C. § 1001; and two counts of shipment in interstate commerce of adulterated drugs in violation of 21 U.S.C. § 331(a) and 333(a)(2).

According to the Indictment, Ratti, former Chief Executive Officer and Chairman of the Board of Directors of Biochimica Opos, S.p.A. (Opos), an Italian company, 1 orchestrated a scheme to falsify manufacturing records and regulatory submissions to the U.S. Food and Drug Administration (FDA) with respect to an antibiotic known as Cefaclor as well as other drug products. The false statements related to the sites and processes involved in the manufacture of the drugs and were purportedly made so that the FDA would not prohibit the importation of drugs into the United States.

Ratti and the Government have filed several motions clustering around two issues:

• First, whether the charges against him have been brought within the applicable period of limitations;'
• Second, and ultimately related to the first issue, whether a proffer agreement between the Government and *652 Ratti was breached by him, such that the Government should be free to use his proffered statements in its case-in-chief at trial. Or, on the other hand, whether the Government has breached the agreement, such that the July 16, 2003 Indictment in these proceedings should be dismissed. In conjunction with the latter, Ratti has moved the Court for leave to inspect the record of the proceedings before the September 2004 Grand Jury that returned the Superseding Indictment, or in the alternative, to have the Court conduct an in camera review of the record to determine the extent to which the deliberations of the second Grand Jury may have been tainted by the first Grand Jury’s improper consideration of the proffer statements.

II. Statute of Limitations

A) Each of the crimes with which Ratti is charged is subject to a five-year statute of limitations. See 18 U.S.C. § 3292(a). Where, however, a criminal prosecution depends on obtaining evidence from a foreign jurisdiction, provided certain conditions are met, the statute of limitations for crimes may be extended for up to three years. See 18 U.S.C. § 3292. Ratti contends that those conditions were not met in this case and that his prosecution on all charges is time-barred. The Government submits that it has complied with all the conditions of Section 3292 and that the first Indictment returned in this case on July 16, 2003 fell within the eight year total limitations period provided under Section 3292.

The statute sets the stage for the discussion which follows:

§ 3292. Suspension of limitations to permit United States to obtain foreign evidence
(a) (1) Upon application of the United States, filed before return of an indictment, indicating that evidence of an offense is in a foreign country, the district court before which a grand jury is impaneled to investigate the offense shall suspend the running of the statute of limitations for the offense if the court finds by a preponderance of the evidence that an official request has been made for such evidence and that it reasonably appears, or reasonably appeared at the time the request was made, that such evidence is, or was, in such foreign country.
(2) The Court shall rule upon such application not later than thirty days after the filing of the application.
(b) Except as provided in subsection (c) of this section, a period of suspension under this section shall begin on the date on which the official request is made and end on the date on which the foreign court or authority takes final action on the request.
(c) The total of all periods of suspension under this section with respect to an offense-
(1) shall not exceed three years; and
(2) shall not extend a period within which a criminal case must be initiated for more than six months if all foreign authorities take final action before such period would expire without regard to this section.
(d) As used in this section, the term “official request” means a letter ro-gatory, a request under a treaty or convention, or any other request for evidence made by a court of the United States or an authority of the United States having criminal law *653 enforcement responsibility, to a court or other authority of a foreign country.

B) On April 10, 1998, the Government prepared a Multilateral Assistance Treaty (MLAT) request to Italy, which was delivered on or about April 28, 1998. By its terms, the request to the Italian authorities was “for [assistance in the [ijnvestigation of [e]mployees of Roussel Uclaf; Roussel Corporation; and Biochemica Opos S.p.A.” The opening paragraph indicated that an Assistant Attorney General for the United States was conducting an investigation to determine whether employees of Roussel Uclaf ... Roussel Corporation ... and Opos ... violated United States criminal laws by the importation of Italian-made antibiotics into the United States that had not been approved by the United States Food and Drug Administration ... and by making false statements to officials of the FDA about the processes used to manufacture these drugs. The request asked the Italian authorities to: (1) compel the production of Opos documents and have them authenticated as business records by an appropriate custodian; and (2) interview at least eight individuals including Luigi Ratti, as well as Mario Moretti, a former Opos production manager, and a “Mr.” Potere, a former Opos production supervisor. All the prospective interviewees were identified as individuals who had been named as responsible individuals in FDA inspection of Opos or Archimica. The request asked that each of these individuals be questioned, about whether, among others, “Luigi Ratti ... Opos employees, or Roussel employees [knew] about or [played] a role” in outsourcing the manufacture of the drugs or in any attempt to mislead the FDA or any customer about practices of the corporations.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Michel
District of Columbia, 2019
Perez v. Ponte
236 F. Supp. 3d 590 (E.D. New York, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
365 F. Supp. 2d 649, 2005 U.S. Dist. LEXIS 6268, 2005 WL 878093, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-ratti-mdd-2005.